The role of the ERK1/2 pathway as an alternative to the aging-diminished cyclic AMP pathway in calcitonin-mediated chondrogenesis in human nucleus pulposus.

[1]  D. Henning.  Metabolism , 1972, Introduction to a Phenomenology of Life.

[2]  Wei-Hong Chen,et al.  Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. , 2011, Biomaterials.

[3]  M. Karsdal,et al.  Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes , 2010, BMC musculoskeletal disorders.

[4]  F. Lin,et al.  Influence of age‐related degeneration on regenerative potential of human nucleus pulposus cells , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  I. Shapiro,et al.  BMP-2 and TGF-β Stimulate Expression of β1,3-Glucuronosyl Transferase 1 (GlcAT-1) in Nucleus Pulposus Cells Through AP1, TonEBP, and Sp1: Role of MAPKs , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Wei-Hong Chen,et al.  Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. , 2009, Biomaterials.

[7]  S. Hung,et al.  In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. , 2009, Arthritis and rheumatism.

[8]  Koichi Masuda,et al.  Age-Related Changes in the Extracellular Matrix of Nucleus Pulposus and Anulus Fibrosus of Human Intervertebral Disc , 2009, Spine.

[9]  J. Urban,et al.  Tissue engineering and the intervertebral disc: the challenges , 2008, European Spine Journal.

[10]  J. Cornish,et al.  The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. , 2008, Bone.

[11]  I. Shapiro,et al.  MEK/ERK Signaling Controls Osmoregulation of Nucleus Pulposus Cells of the Intervertebral Disc by Transactivation of TonEBP/OREBP , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  M. Karsdal,et al.  Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. , 2007, Arthritis and rheumatism.

[13]  C. Su,et al.  Tissue‐engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF‐β1 in platelet‐rich plasma , 2006, Journal of cellular physiology.

[14]  E. Thonar,et al.  Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. , 2006, Arthritis and rheumatism.

[15]  M. Karsdal,et al.  Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. , 2006, Osteoarthritis and cartilage.

[16]  M. Karsdal,et al.  Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? , 2006, Osteoarthritis and cartilage.

[17]  Wen-Cheng Lo,et al.  Tissue engineered cartilage using human articular chondrocytes immortalized by HPV-16 E6 and E7 genes. , 2006, Journal of biomedical materials research. Part A.

[18]  T. Albert,et al.  Hypoxia Activates MAPK Activity in Rat Nucleus Pulposus Cells: Regulation of Integrin Expression and Cell Survival , 2005, Spine.

[19]  M. Karsdal,et al.  Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. , 2005, Bone.

[20]  W. Deng,et al.  Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  T. Albert,et al.  Differentiation of Mesenchymal Stem Cells Towards a Nucleus Pulposus-like Phenotype In Vitro: Implications for Cell-Based Transplantation Therapy , 2004, Spine.

[22]  S. Ferguson,et al.  Biomechanics of the aging spine , 2003, European Spine Journal.

[23]  J. Matyas,et al.  The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. , 2003, Tissue engineering.

[24]  S. Suzuki,et al.  Age-related changes in expression of transforming growth factor-beta and receptors in cells of intervertebral discs. , 2003, Journal of neurosurgery.

[25]  T. Huh,et al.  Maintenance of Differentiated Phenotype of Articular Chondrocytes by Protein Kinase C and Extracellular Signal-regulated Protein Kinase* , 2002, The Journal of Biological Chemistry.

[26]  P. Sexton,et al.  Molecular pharmacology of the calcitonin receptor. , 2002, Receptors & channels.

[27]  R. Fessler,et al.  Molecular Biology of Degenerative Disc Disease , 2000, Neurosurgery.

[28]  V. Lefebvre,et al.  Transcriptional mechanisms of chondrocyte differentiation. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[29]  R. Baron,et al.  The Calcitonin Receptor Stimulates Shc Tyrosine Phosphorylation and Erk1/2 Activation , 1998, The Journal of Biological Chemistry.

[30]  E. Vignon,et al.  Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes. , 1997, Osteoarthritis and cartilage.

[31]  Phillippe Schoeffter,et al.  Age-related differences in cyclic AMP metabolism and their consequences on relaxation induced by isoproterenol and phosphodiesterase inhibitors in rat isolated aorta , 1990, Mechanisms of Ageing and Development.

[32]  Y. Henrotin,et al.  Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters. , 1989, The Journal of clinical endocrinology and metabolism.

[33]  J. Krall,et al.  Human Aging: Effect on the Activation of Lymphocyte Cyclic AMP-Dependent Protein Kinase by Forskolin 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  E. Faragher,et al.  Effect of ageing on cyclic AMP output by renal medullary cells in response to arginine vasopressin in vitro in C57BL/Icrfat mice. , 1984, The Journal of endocrinology.

[35]  T. Martin,et al.  Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. , 1977, British Journal of Cancer.

[36]  M. Hollinger.  Effect of age, cryptorchidism and hypophysectomy on cyclic AMP concentration in rat testis. , 1973, Journal of reproduction and fertility.

[37]  D. Copp,et al.  Calcitonin—a Hormone from the Parathyroid which Lowers the Calcium-level of the Blood , 1962, Nature.